Inuvo (INUV) Misses Q2 EPS by 14c

Inuvo (NYSE: INUV) reported Q2 EPS of ($0.27), $0.14 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.53 million versus the consensus estimate of $7.76 million.

For earnings history and earnings-related data on Inuvo (INUV) click here.

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
• Pharvaris B.V. (PHVS) PT Raised to $75 at Citizens: Has Cash Runway Into 2028
• Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss